Article Details

New 5-Year Data Highlight Erenumab's Efficacy, Safety

Retrieved on: 2021-01-12 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

New 5-Year Data Highlight Erenumab's Efficacy, Safety. View article details on hiswai:

Excerpt

Erenumab, a monoclonal antibody, was approved by the FDA in 2018 and is administered monthly via self-injection of a 70- or 140-mg dose.

Article found on: www.ajmc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo